Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Genomics Used to Improve DEpression Decisions

ClinicalTrials.gov ID: NCT02109939

Public ClinicalTrials.gov record NCT02109939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

12 Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From A Major Depressive Disorder (MDD) Having Had- Within the Current Episode- An Inadequate Response to at Least One Medication Included in GeneSight Psychotropic

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Evaluate the impact of GeneSight Psychotropic on response to psychotropic treatment as judged by the mean change in the 17-item Hamilton Depression (HAM-D17) score from baseline to end of Week 8 of the study.

Study identification

NCT ID
NCT02109939
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Assurex Health Inc.
Industry
Enrollment
1,398 participants

Conditions and interventions

Interventions

Genetic

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2014 (Actual)
Primary completion
Apr 20, 2017 (Actual)
Completion
Jul 31, 2017 (Actual)
Last update posted
Jan 14, 2020

2014 – 2017

United States locations

U.S. sites
61
U.S. states
26
U.S. cities
55
Facility City State ZIP Site status
Birmingham Psychiatry Pharmaceutical Studies Birmingham Alabama 35226 —
University of Alabama at Birmingham Birmingham Alabama 35233 —
CiTrials Bellflower California 90706 —
Catalina Research Institute Chino California 91710 —
CiTrials Costa Mesa California 92705 —
Synergy Research Center Escondido California 92025 —
Pharmacology Research Institute Los Alamitos California 90720 —
North County Research Oceanside California 92056 —
CiTrials Riverside California 92506 —
Stanford School of Medicine Stanford California 94304 —
Viking Clinical Research Temecula California 92591 —
Elite Clinical Trials, Inc Wildomar California 92595 —
MCB Clinical Research Centers, LLC Colorado Springs Colorado 80910 —
Howard University Hospital Mental Health Clinic Washington D.C. District of Columbia 20060 —
Sarkis Clinical Trials Gainesville Florida 32607 —
Clinical Neuroscience Solutions Healthcare Jacksonville Florida 32256 —
Clinical Neuroscience Solutions Orlando Florida 32801 —
Clinical Research Trials of Florida, Inc Tampa Florida 33607 —
Stedman Clinical Trials Tampa Florida 33613 —
Janus Center For Psychiatric Research West Palm Beach Florida 33407 —
Atlanta Institute of Medicine and Research Atlanta Georgia 30328 —
Mood and Anxiety Program at Emory University Atlanta Georgia 30329 —
Meridian Clinical Research Savannah Georgia 31406 —
Carman Research Smyrna Georgia 30080 —
Rush University Medical Center Chicago Illinois 60612 —
Behavioral Healthcare Associates Schaumburg Illinois 60194 —
The Institute of Psychiatric Research Indianapolis Indiana 46202 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
Kansas University Medical Center- Clinical Trials Unit Wichita Kansas 67214 —
Pharmasite Research Baltimore Maryland 21208 —
Johns Hopkins Hospital Baltimore Maryland 21224 —
Geriatric Outpatient Unit- McLean Hospital Belmont Massachusetts 02478 —
Boston Clinical Trials Boston Massachusetts 02131 —
UMASS Center for Psychopharmacologic Research and Treatment Worcester Massachusetts 01655 —
University of Michigan Ann Arbor Michigan 48109 —
University of Minnesota Minneapolis Minnesota 55454 —
Washington University School of Medicine St Louis Missouri 63110 —
PsychCare Consultants Research St Louis Missouri 63128 —
Meridian Clinical Research Bellevue Nebraska 68005 —
Premier Psychiatric Research Institute, LLC Lincoln Nebraska 68526 —
United Medical Research Associates Binghamton New York 13901 —
Integrative Clinical Trials, LLC Brooklyn New York 11229 —
SPRI Clinical Trials Brooklyn New York 11235 —
Eastside Comprehensive Medical Center, LLC New York New York 10021 —
Finger Lakes Clinical Research Rochester New York 14618 —
University of Cincinnati Health Cincinnati Ohio 45267 —
Cleveland Clinic Cleveland Ohio 44120 —
Ohio State University Department of Psychiatry Columbus Ohio 43210 —
Midwest Clinical Research Center Dayton Ohio 45417 —
Oklahoma Clinical Research Center Oklahoma City Oklahoma 73112 —
Summit Research Network Portland Oregon 97210 —
Suburban Research Associates Media Pennsylvania 19063 —
Mood and Anxiety Disorders Treatment and Research Philadelphia Pennsylvania 19104 —
Lincoln Research Lincoln Rhode Island 02865 —
Clinical Neuroscience Solutions Memphis Tennessee 38119 —
University of Texas Southwestern Medical Center Dallas Texas 76034 —
Baylor College of Medicine Houston Texas 77030 —
Alliance Research Group Richmond Virginia 20230 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Summit Research Network Seattle Washington 98104 —
Frontier Institute Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02109939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 14, 2020 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02109939 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →